COM:TCR2
Adaptimmune
- Stock
Last Close
1.48
31/05 20:00
Market Cap
58.11M
Beta: -
Volume Today
3.75M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | ||||||||
average payables | 467.50K - | 1.54M 230.48% | 2.57M 66.54% | 2.47M 4.18% | 2.30M 6.87% | 2.47M 7.51% | ||
average receivables | ||||||||
book value per share | -2.32 - | -5.13 121.51% | -3.70 27.95% | 7.60 305.73% | 8.45 11.16% | 7.42 12.20% | 3.65 50.85% | |
capex per share | -0.17 - | -0.08 55.35% | -0.04 41.87% | -0.18 318.29% | -0.26 39.25% | -0.30 17.92% | -0.40 32.54% | |
capex to depreciation | -3.95 - | -1.30 67.04% | -2.43 86.79% | -4.50 85.03% | -4.50 0% | -4.05 10.00% | -5.07 25.26% | |
capex to operating cash flow | 0.09 - | 0.03 65.20% | 0.05 68.34% | 0.09 72.83% | 0.13 34.62% | 0.14 11.12% | 0.15 8.55% | |
capex to revenue | ||||||||
cash per share | 3.18 - | 3.86 21.24% | 5.31 37.60% | 7.49 41.07% | 8.15 8.71% | 7.00 14.04% | 3.86 44.84% | |
days of inventory on hand | ||||||||
days payables outstanding | ||||||||
days sales outstanding | ||||||||
debt to assets | 0.08 - | 0.26 216.68% | ||||||
debt to equity | 0.09 - | 0.38 307.50% | ||||||
dividend yield | ||||||||
earnings yield | -0.13 - | -0.17 31.82% | -0.07 58.93% | -0.16 127.61% | -0.08 50.91% | -0.56 628.19% | -3.94 596.99% | |
enterprise value | 69.35M - | 57.54M 17.04% | 301.80M 424.54% | 236.07M 21.78% | 771.59M 226.85% | -19.42M 102.52% | 59.60M 406.86% | |
enterprise value over ebitda | -7.15 - | -4.50 37.03% | -12.66 181.11% | -4.67 63.10% | -11.50 146.06% | 0.20 101.74% | -0.67 431.84% | |
ev to operating cash flow | -7.39 - | -4.78 35.35% | -16.07 236.21% | -5.71 64.49% | -13.60 138.25% | 0.24 101.75% | -0.59 346.80% | |
ev to sales | ||||||||
free cash flow per share | -2.00 - | -2.42 21.22% | -0.85 64.73% | -2.14 151.09% | -2.28 6.51% | -2.45 7.44% | -3.03 23.39% | |
free cash flow yield | -0.13 - | -0.16 21.22% | -0.06 64.73% | -0.15 164.98% | -0.07 50.83% | -0.53 613.12% | -3.03 475.69% | |
graham net net | -2.69 - | -5.56 106.97% | -3.97 28.71% | 7.11 279.28% | 7.80 9.72% | 5.90 24.40% | 2.12 64.09% | |
graham number | 10.03 - | 17.14 70.88% | 9.32 45.60% | 19.64 110.65% | 21.35 8.71% | 20.96 1.85% | 17.96 14.32% | |
income quality | 0.95 - | 0.92 2.66% | 0.77 15.92% | 0.87 12.22% | 0.85 2.72% | 0.82 3.27% | 0.67 18.26% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | 13.23 - | 39.55 199.05% | 445.28 1,025.83% | -2.61 100.59% | ||||
interest debt per share | -0.18 - | -0.06 66.29% | 0.69 1,210.34% | 2.92 323.26% | ||||
inventory turnover | ||||||||
invested capital | 0.09 - | 0.38 307.50% | ||||||
market cap | 77.35M - | 77.35M 0% | 349.47M 351.82% | 301.37M 13.76% | 865.75M 187.27% | 176.78M 79.58% | 38.58M 78.18% | |
net current asset value | -12.82M - | -27.66M 115.76% | -89.64M 224.06% | 155.11M 273.04% | 225.89M 45.64% | 234.23M 3.69% | 110.24M 52.93% | |
net debt to ebitda | 0.82 - | 1.55 88.17% | 2.00 28.97% | 1.29 35.39% | 1.40 8.55% | 2.02 44.29% | -0.23 111.58% | |
net income per share | -1.93 - | -2.55 31.82% | -1.05 58.93% | -2.26 115.67% | -2.40 6.33% | -2.63 9.71% | -3.93 49.39% | |
operating cash flow per share | -1.83 - | -2.35 28.32% | -0.81 65.47% | -1.96 142.02% | -2.03 3.44% | -2.15 6.12% | -2.63 22.11% | |
payables turnover | ||||||||
receivables turnover | ||||||||
research and ddevelopement to revenue | ||||||||
return on tangible assets | -0.54 - | -0.59 9.16% | -0.19 68.41% | -0.28 50.74% | -0.27 3.47% | -0.31 13.20% | -0.73 136.22% | |
revenue per share | ||||||||
roe | 0.83 - | 0.50 40.49% | 0.28 43.00% | -0.30 204.83% | -0.28 4.35% | -0.35 24.96% | -1.08 203.97% | |
roic | -5.65 - | 0.73 112.96% | -0.84 215.04% | -1.45 72.52% | -1.24 14.47% | 0.81 164.99% | -1.10 236.09% | |
sales general and administrative to revenue | ||||||||
shareholders equity per share | -2.32 - | -5.13 121.51% | -3.70 27.95% | 7.60 305.73% | 8.45 11.16% | 7.42 12.20% | 3.65 50.85% | |
stock based compensation to revenue | ||||||||
tangible asset value | -11.88M - | -26.32M 121.51% | -85.70M 225.54% | 160.45M 287.23% | 236.55M 47.43% | 281.48M 18.99% | 140.86M 49.96% | |
tangible book value per share | -2.32 - | -5.13 121.51% | -3.70 27.95% | 7.60 305.73% | 8.45 11.16% | 7.42 12.20% | 3.65 50.85% | |
working capital | 16.35M - | 19.47M 19.10% | 120.03M 516.41% | 155.65M 29.68% | 226.70M 45.64% | 257.52M 13.60% | 113.56M 55.90% |
All numbers in (except ratios and percentages)